XtalPi Holdings Ltd. has announced the successful development and validation of two innovative topical ingredients for hair loss prevention and hair growth, named Remeanagen™ (XTP-118) and GEMINI. Leveraging its AI-driven R&D platform, XtalPi has utilized advanced quantum physics, artificial intelligence, and high-performance cloud computing to create these new molecules. The company also reported that these molecules have obtained key international certificates. The announcement did not specify whether the scientific research results have already been presented or will be presented at a future event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.
Comments